It has been an exciting year for the Gothenburg-based company Intelligent Implants. Initial preparations for the first clinical study, which is to include between ten and twenty patients, has been completed. The next step is to perform the clinical study and to evaluate its findings.
Ten years of work pays off
CFO Martin Larsson is very excited about the developments. Funding has already been secured for the first clinical part I study, thus enabling the long-term plan of action to be presented. Larsson explains that the recent developments are what founders, researchers and employees at Intelligent Implants have been working towards over the last ten years.
“It feels amazing to be so close to our biggest goal since we started up business in 2014. If our technology and our implants work as well in clinical studies as in our animal studies, we will be able to introduce a completely new line of products on the market. With smart implants we can enable a better everyday life for patients and help to increase the quality of life for thousands of people worldwide”.
Undoubtedly, the biggest commercial market is North America. Veteran soldiers make up a very large target group, but they are not the only potential patients that can benefit from smart implants. Victims of work-related and/or motor accidents also make up a significant target group.
Now entering the next stage
Intelligent Implants has worked purposefully to strengthen and develop the team with more interdisciplinary competence. That work will continue to ensure that the company has all the skills needed to run and evaluate the first clinical trials successfully. Now is the time to really manifest all that hard work, and to reap the benefits of being a big step closer to the company’s commercial goal.
Intelligent Implants is now entering the next stage as a commercial supplier of medical technology solutions. This has further been clarified as the company moved out of the incubator environment at AstraZeneca’s Bioventure Hub to its own premises at Goco Health Innovation City last year.
“Our new premises provide us with every opportunity we need to continue our journey of growth, both in terms of more employees, more collaborations and more innovations. At the same time, we are still part of the same community that we have been since we started up at Bioventure Hub several years back, and this provides a lot of know-how and security to our team”, says Martin Larsson.
